This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Eisai R&D Management Co., Ltd., Merck Sharp & Dohme LLC, Msd International Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 13 
1 out of 72 
1 out of 9 Years Active: 2026
Title: Yoichi Ozawa: Cancer-Treatment Patent Inventor
Introduction
Yoichi Ozawa is an inventor associated with Tsukuba, Japan. His listed patent concerns a combination of targeted therapies for treating cancer.
Latest Patents
Ozawa is associated with one patent: “Combination of a PD-1 Antagonist, a VEGFR/FGFR/RET Tyrosine Kinase Inhibitor and a CBP/Beta-Catenin Inhibitor for Treating Cancer.” The invention describes combining a PD-1 antagonist with inhibitors targeting specified tyrosine kinases and the CBP/beta-catenin pathway.
Career Highlights
Ozawa’s listed professional affiliations include Merck Sharp & Dohme LLC and MSD International GmbH. His patent work reflects research into combination approaches for cancer treatment.
Collaborations
His listed coworkers include Yu Kato and Yasuhiro Funahashi, who are also associated with the cancer-treatment patent.
Conclusion
Yoichi Ozawa’s recorded patent activity centers on a combination therapy approach to cancer treatment, alongside professional affiliations and collaborations in pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile